Perrigo to Conduct Strategic Review of its Infant Formula Business
Go back to Perrigo to Conduct Strategic Review of its Infant Formula Business| Perrigo (NYSE: PRGO) | Delayed: 14.48 +0.05 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.43 | 52 Week High | $156.03 | |||
| Open | $14.45 | 52 Week Low | $79.72 | |||
| Day High | $14.85 | P/E | N/A | |||
| Day Low | $14.30 | EPS | $0.00 | |||
| Volume | 1,973,160 | |||||
